长效抗艾滋病毒药物取得进展以克服依从性挑战。 - Suppr

Suppr

超能文献

Long-acting HIV drugs advanced to overcome adherence challenge.

作者信息

Dolgin Elie

出版信息

Nat Med. 2014 Apr;20(4):323-4. doi: 10.1038/nm0414-323.

DOI:10.1038/nm0414-323

PMID:24710366

Abstract

摘要

相似文献

Long-acting HIV drugs advanced to overcome adherence challenge.长效抗艾滋病毒药物取得进展以克服依从性挑战。

Nat Med. 2014 Apr;20(4):323-4. doi: 10.1038/nm0414-323.

Long-acting injectable antiretrovirals for HIV treatment and prevention.长效注射型抗逆转录病毒药物治疗和预防艾滋病。

Curr Opin HIV AIDS. 2013 Nov;8(6):565-71. doi: 10.1097/COH.0000000000000002.

Long-acting injectable for HIV approved for use in the UK.长效注射用抗艾滋病毒药物在英国获批使用。

Lancet Infect Dis. 2022 Jan;22(1):26. doi: 10.1016/S1473-3099(21)00775-1.

Rilpivirine (Edurant)--a new drug for HIV infection.利匹韦林（依非伦）——一种用于治疗艾滋病毒感染的新药。

Med Lett Drugs Ther. 2011 Aug 22;53(1371):67-8.

[Pharmacological properties of rilpivirine (Edurant Tablet), a new drug for the treatment of HIV, and results of its clinical studies].

Nihon Yakurigaku Zasshi. 2013 Apr;141(4):205-11. doi: 10.1254/fpj.141.205.

Implementing long-acting injectable cabotegravir and rilpivirine in Africa.在非洲推广长效注射用卡博特韦和利匹韦林。

Lancet Infect Dis. 2024 Oct;24(10):1060-1061. doi: 10.1016/S1473-3099(24)00296-2. Epub 2024 May 28.

Boceprevir, telaprevir, and rilpivirine hydrochloride.博赛泼维、替拉泼维及盐酸利匹韦林。

J Am Pharm Assoc (2003). 2012 Jan-Feb;52(1):120-6. doi: 10.1331/JAPhA.2012.12506.

[Introduction. Rilpivirine].[引言。利匹韦林]

Enferm Infecc Microbiol Clin. 2013 Jun;31 Suppl 2:1. doi: 10.1016/S0213-005X(13)70135-6.

[Conclusions. Position of rilpivirine in the management of infection by the human immunodeficiency virus].[结论。利匹韦林在人类免疫缺陷病毒感染管理中的地位]

Enferm Infecc Microbiol Clin. 2013 Jun;31 Suppl 2:44. doi: 10.1016/S0213-005X(13)70142-3.

Emtricitabine/rilpivirine/tenofovir disoproxil fumarate single-tablet regimen: a guide to its use in HIV-1 infection.恩曲他滨/利匹韦林/富马酸替诺福韦二吡呋酯单片复方制剂：在人类免疫缺陷病毒 1 型感染中的应用指南。

Clin Drug Investig. 2012 Oct 1;32(10):715-22. doi: 10.1007/BF03261925.

引用本文的文献

Two phase 1 studies of safety, tolerability, and pharmacokinetics of an EFdA prodrug (BRII-732) in healthy adult participants.关于一种EFdA前药（BRII-732）在健康成年受试者中的安全性、耐受性和药代动力学的两项1期研究。

Antimicrob Agents Chemother. 2025 Jun 4;69(6):e0020025. doi: 10.1128/aac.00200-25. Epub 2025 Apr 22.

Antiviral supramolecular polymeric hydrogels by self-assembly of tenofovir-bearing peptide amphiphiles.基于含替诺福韦的两亲肽自组装的抗病毒超分子聚合物水凝胶。

Biomater Sci. 2023 Jan 17;11(2):489-498. doi: 10.1039/d2bm01649d.

Fundamental aspects of long-acting tenofovir alafenamide delivery from subdermal implants for HIV prophylaxis.长效替诺福韦艾拉酚胺经皮下植入剂给药用于 HIV 预防的基本问题。

Sci Rep. 2022 May 17;12(1):8224. doi: 10.1038/s41598-022-11020-2.

A situation analysis of competences of research ethics committee members regarding review of research protocols with complex and emerging study designs in Uganda.乌干达研究伦理委员会成员对复杂和新兴研究设计研究方案审查的能力情况分析。

BMC Med Ethics. 2021 Sep 26;22(1):132. doi: 10.1186/s12910-021-00692-6.

Poly(ethylene glycol)--poly(1,3-trimethylene carbonate) Amphiphilic Copolymers for Long-Acting Injectables: Synthesis, Non-Acylating Performance and In Vivo Degradation.聚（乙二醇）-聚（1,3-三亚甲基碳酸酯）两亲嵌段共聚物长效注射剂：合成、非酯化性能及体内降解。

Molecules. 2021 Mar 6;26(5):1438. doi: 10.3390/molecules26051438.

Reduced efficacy of HIV-1 integrase inhibitors in patients with drug resistance mutations in reverse transcriptase.逆转录酶耐药突变患者中 HIV-1 整合酶抑制剂疗效降低。

Nat Commun. 2020 Dec 1;11(1):5922. doi: 10.1038/s41467-020-19801-x.

Trans-urocanic acid enhances tenofovir alafenamide stability for long-acting HIV applications.反式尿刊酸增强替诺福韦艾拉酚胺的稳定性，用于长效 HIV 应用。

Int J Pharm. 2020 Sep 25;587:119623. doi: 10.1016/j.ijpharm.2020.119623. Epub 2020 Jul 11.

Development and validation of a multiplex UHPLC-MS/MS assay with stable isotopic internal standards for the monitoring of the plasma concentrations of the antiretroviral drugs bictegravir, cabotegravir, doravirine, and rilpivirine in people living with HIV.建立并验证了一种采用稳定同位素内标物的多重 UHPLC-MS/MS 分析方法，用于监测 HIV 感染者体内比克替拉韦、卡替拉韦、多拉韦林和利匹韦林这 4 种抗逆转录病毒药物的血浆浓度。

J Mass Spectrom. 2020 Jun;55(6):e4506. doi: 10.1002/jms.4506. Epub 2020 Mar 11.

Design of Poly(lactic--glycolic Acid) (PLGA) Nanoparticles for Vaginal Co-Delivery of Griffithsin and Dapivirine and Their Synergistic Effect for HIV Prophylaxis.用于阴道共同递送格里菲斯素和地匹韦林的聚乳酸-乙醇酸共聚物（PLGA）纳米颗粒的设计及其对HIV预防的协同作用

Pharmaceutics. 2019 Apr 16;11(4):184. doi: 10.3390/pharmaceutics11040184.

Long-Acting Injectable Antiretroviral Treatment Acceptability and Preferences: A Qualitative Study Among US Providers, Adults Living with HIV, and Parents of Youth Living with HIV.长效注射型抗逆转录病毒治疗的可接受性和偏好：一项在美国医护人员、HIV 感染者成人和 HIV 感染青年父母中开展的定性研究。

AIDS Patient Care STDS. 2019 Mar;33(3):104-111. doi: 10.1089/apc.2018.0198.

本文引用的文献

Long-acting integrase inhibitor protects macaques from intrarectal simian/human immunodeficiency virus.长效整合酶抑制剂可预防猕猴的直肠内猴免疫缺陷病毒/人免疫缺陷病毒感染。

Science. 2014 Mar 7;343(6175):1151-4. doi: 10.1126/science.1248707. Epub 2014 Mar 4.

Preclinical pharmacokinetics and tissue distribution of long-acting nanoformulated antiretroviral therapy.长效纳米剂型抗逆转录病毒治疗的临床前药代动力学和组织分布。

Antimicrob Agents Chemother. 2013 Jul;57(7):3110-20. doi: 10.1128/AAC.00267-13. Epub 2013 Apr 22.

Long-acting parenteral nanoformulated antiretroviral therapy: interest and attitudes of HIV-infected patients.长效注射型纳米载药抗逆转录病毒疗法：HIV 感染者的兴趣和态度。

Nanomedicine (Lond). 2013 Nov;8(11):1807-13. doi: 10.2217/nnm.12.214. Epub 2013 Apr 23.

Long-acting nanoformulated antiretroviral therapy elicits potent antiretroviral and neuroprotective responses in HIV-1-infected humanized mice.长效纳米剂型抗逆转录病毒疗法在感染 HIV-1 的人源化小鼠中引发强烈的抗逆转录病毒和神经保护反应。

AIDS. 2012 Nov 13;26(17):2135-44. doi: 10.1097/QAD.0b013e328357f5ad.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验